Dhruv Wellness Ltd
₹ 4.58
-4.78%
29 Sep 2025
About
Incorporated in 2015, Dhruv Wellness Ltd is in the business of trading pharmaceutical and cosmetic items.[1]
Key Points
- Market Cap ₹ 4.83 Cr.
- Current Price ₹ 4.58
- High / Low ₹ 4.58 / 4.58
- Stock P/E
- Book Value ₹ -13.5
- Dividend Yield 0.00 %
- ROCE 0.37 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of -67.3% over past five years.
- Company has high debtors of 2,592 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2016 13m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|
| 22.72 | 101.92 | 103.66 | 116.93 | 42.33 | 0.00 | 0.37 | 0.39 | |
| 22.22 | 100.04 | 100.95 | 113.58 | 65.16 | 5.15 | 0.35 | 0.37 | |
| Operating Profit | 0.50 | 1.88 | 2.71 | 3.35 | -22.83 | -5.15 | 0.02 | 0.02 |
| OPM % | 2.20% | 1.84% | 2.61% | 2.86% | -53.93% | 5.41% | 5.13% | |
| 0.00 | 0.02 | 0.02 | 0.12 | 0.02 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.21 | 1.30 | 1.98 | 2.68 | 1.85 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.29 | 0.60 | 0.75 | 0.78 | -24.67 | -5.15 | 0.02 | 0.02 |
| Tax % | 31.03% | 33.33% | 26.67% | 28.21% | 0.00% | 0.00% | 50.00% | 0.00% |
| 0.20 | 0.40 | 0.54 | 0.57 | -24.67 | -5.15 | 0.02 | 0.02 | |
| EPS in Rs | 2.00 | 4.00 | 0.51 | 0.54 | -23.41 | -4.89 | 0.02 | 0.02 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -67% |
| 3 Years: | -79% |
| TTM: | -70% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -48% |
| 3 Years: | 26% |
| TTM: | -100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -43% |
| 3 Years: | -35% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.00 | 1.00 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 |
| Reserves | 4.66 | 5.06 | 4.45 | 5.02 | -19.65 | -24.81 | -24.79 | -24.77 |
| 9.41 | 10.04 | 16.56 | 20.69 | 19.71 | 19.71 | 19.71 | 19.71 | |
| 11.54 | 13.15 | 5.62 | 10.88 | 1.23 | 0.75 | 0.67 | 0.72 | |
| Total Liabilities | 26.61 | 29.25 | 37.17 | 47.13 | 11.83 | 6.19 | 6.13 | 6.20 |
| 0.16 | 3.02 | 3.44 | 3.47 | 3.50 | 3.44 | 3.44 | 3.44 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.38 | 0.27 | 0.29 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| 26.07 | 25.96 | 33.44 | 43.35 | 8.33 | 2.75 | 2.69 | 2.76 | |
| Total Assets | 26.61 | 29.25 | 37.17 | 47.13 | 11.83 | 6.19 | 6.13 | 6.20 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|
| -14.44 | 3.74 | -9.76 | -2.71 | 1.30 | -0.06 | 0.00 | 0.00 | |
| -0.15 | -2.85 | -0.41 | -0.01 | -0.02 | 0.06 | 0.00 | 0.00 | |
| 14.66 | -0.67 | 10.33 | 2.30 | -1.30 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.06 | 0.22 | 0.16 | -0.42 | -0.02 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -14.60 | 0.87 | -10.18 | -2.74 | 1.26 | 0.00 | 0.00 | 0.00 |
| CFO/OP | -2,888% | 205% | -354% | -75% | -6% | 1% | 0% | 0% |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 297.04 | 60.85 | 76.13 | 72.04 | 62.95 | 2,653.65 | 2,592.44 | |
| Inventory Days | 123.10 | 31.83 | 39.83 | 63.17 | 4.27 | 0.00 | 0.00 | 0.00 |
| Days Payable | 188.79 | 35.40 | 18.31 | 32.70 | 2.52 | |||
| Cash Conversion Cycle | 231.36 | 57.27 | 97.65 | 102.51 | 64.70 | 2,653.65 | 2,592.44 | |
| Working Capital Days | 102.50 | 21.20 | 55.95 | 47.51 | -84.68 | -14,698.65 | -13,926.15 | |
| ROCE % | 12.19% | 11.46% | 10.21% | -97.42% | -64.21% | 0.37% | 0.37% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|
| Permanent employees on rolls count |
|
||||||
| Principal manufacturers (distributorships) count |
|||||||
| Products in trading portfolio count |
|||||||
| Retailers in marketing network count |
|||||||
| Supplier wholesalers (sourcing) count |
|||||||
| Wholesalers in marketing network count |
|||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
- Dhruv Wellness announces Ninth CoC meeting on 8 January 2026, with delay attributed to oversight.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
- Eighth CoC meeting of Dhruv Wellness held on 18 December 2025; proceedings concluded.
-
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
- Eighth CoC meeting of Dhruv Wellness Limited scheduled for 18 December 2025 at 12:30 P.M.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
- Seventh CoC meeting of Dhruv Wellness Limited held on 26 November 2025 and concluded.
-
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
- Seventh CoC meeting of Dhruv Wellness Limited scheduled for 26 November 2025 at 12:00 PM via VC.
Annual reports
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
Business Overview:[1]
DWL is engaged in the trading and distributorship of a wide range of pharmaceutical and cosmetic products, catering mainly to retailers and wholesalers in Mumbai’s western suburbs and outskirts. Its procurement strategy combines direct sourcing from principal manufacturers as an authorized distributor with purchases from other wholesalers, ensuring a broad supply chain. Additionally, DWL manufactures Ayurvedic medicines under its proprietary brand Dhruv, with production fully outsourced to Savita Health Care Private Limited.